News

HungaroTrial CRO Continues Growth with New APAC Office in Seoul

September 05, 2024

HungaroTrial has opened an office in the USA

October 12, 2023

Interview with our Director of Medical Device Unit

September 22, 2023

Newsfeed

EU authorization of a new COVID-19 medication

November 22, 2021

Completion of enrollment

Publishing in Biospectator

New video about our Medical Device Unit

September 08, 2020

We have received approval for a new COVID-19 trial

August 24, 2020

Full service coverage of a Phase I. vaccination clinical trial

February 12, 2020

Proud to Announce: We are ISO 9001 Certified

September 16, 2019

We are announcing the launch of our new Medical Device website

Collaboration in the Largest Phase III Breast Cancer Clinical Trial

November 16, 2018

CEO of HungaroTrial has received his postgraduate degree

February 12, 2018

Announcing the opening of our new office in Prague

September 28, 2017

Successful accomplishment of a device study in acute myocardial infarction

Opening HT Research UK

January 20, 2017

Successful accomplishment of a Phase2 Infectology study

December 19, 2016

Winning Excellence Award from the Cra Academija in Serbia

January 12, 2016

Announce of opening new office in Sofia, Bulgaria

November 16, 2015

HungaroTrial opens up new office in Belgrade, Serbia

January 12, 2015

Selected as the full service provider for a PhaseII. multicenter clinical trial

September 08, 2014

Successfully concluded a Phase III Anal Fissure study

HungaroTrial Featured in Recent Interview on CEbiotech.com

HungaroTrial launches Clinical Trials Webinar Series

HungaroTrial extends its reach to two additional countries

HungaroTrial.com – brand new image

January 10, 2012

Come friend us on Facebook

January 03, 2012

Follow HungaroTrial on Twitter!

January 03, 2012

HungaroTrial transforms into closed corporation